Global Hyperacusis Drug Market – Industry Trends and Forecast to 2026

  • Pharmaceutical
  • Upcoming Report
  • Aug 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Hyperacusis Drug Market By Type (Cochlea Hyperacusis, Vestibular Hyperacusis), Therapy Type (Cognitive Behavioral Therapy (CBT), Sound Therapy), Mechanism of Action (Benzodiazepines, Anti-Depressants, Anti-Migraine Drugs, Anti-Seizure Drugs), Drugs Type (Lorazepam, Alprazolam, Clonazepam, Clomipramine, Desipramine, Others), Devices Types (Ear Plugs, Maskers/Sound Generators, PE Tubes, Others), Route of Administration (Oral, Intravenous and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Hyperacusis Drug Market

Global hyperacusis drug market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the high prevalence of hyperacusis and the lack of any approved treatment options. Rising investment in the research & development of treatments for hyperacusis is expected to drive the market.

Market Definition: Global Hyperacusis Drug Market

A patient becomes over sensitive to certain frequencies to a certain volume range, making them uncomfortable which generally appears normal to other people. This condition occurs due to ototoxic drugs, cochlear damage which often results due to damage caused by loud noises. The patients with hyperacusis become uncomfortable to the daily noises such as traffic noises, machinery noises, crisp sharp noises and among others.

Market Drivers

  • Adoption of unhealthy habits like consumption of alcohol, smoking cigarettes, consuming caffeinated beverages are some of the driving factors for increasing market growth
  • Rising investment in the research & development of treatments for hyperacusis is expected to drive the market
  • Government initiative to increase awareness as well as to provide affordable healthcare is elevating the market growth

Market Restraints

  • Lack of awareness amongst people about hyperacusis is hampering the market growth
  • Lack of any approved drug or treatment option also hampers the market growth

Segmentation: Global Hyperacusis Drug Market

By Type

  • Cochlea Hyperacusis
  • Vestibular Hyperacusis

By Therapy Type

  • Cognitive Behavioral Therapy (CBT)
  • Sound Therapy

By Mechanism of Action

  • Benzodiazepines
  • Anti-Depressants
  • Anti-Migraine Drugs
  • Anti-Seizure Drugs

By Drugs Type

  • Lorazepam
  • Alprazolam
  • Clonazepam
  • Clomipramine
  • Desipramine
  • Others

By Devices Types

  • Ear Plugs
  • Maskers/Sound Generators
  • PE Tubes
  • Others

By Route of Administration

  • Oral
  • Intravenous
  • Others

By End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • United Kingdom
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East & Africa

    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In June 2019, Otonomy Inc. initiated phase II clinical trial for the lead candidate OTO-313, a sustained-exposure formulation of the N-Methyl-D-Aspartate (NMDA) receptor antagonist gacyclidine for the treatment of tinnitus. At present there is no approved drug for the treatment of tinnitus and hyperacusis and if OTO-313 is approved it will provide the new significant treatment options for tinnitus and hyperacusis
  • In April 2019, Sinclair research and Turner Scientific CROs signed an exclusive partnership for the rapid advancement of otic research. These CROs will provide the ototoxicity testing services and guide the patients to protect their ears

Competitive Analysis:

Global hyperacusis drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hyperacusis drug market for Global Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players:

The key market players in the global hyperacusis drug market are Pfizer Inc, Teva Pharmaceutical Industries Ltd, Mylan N.V, Sun Pharmaceutical Industries Ltd, Novartis AG, Mallinckrodt plc, Abbott, Auris Medical, Bayer AG, GlaxoSmithKline plc, Sound Pharmaceuticals, Merz Pharma, Amneal Pharmaceuticals LLC., Zydus Pharmaceuticals, Inc, LUPIN, Torrent Pharmaceuticals Ltd, Intas Pharmaceuticals Ltd, Sanofi, AA Pharma Inc, Hikma Pharmaceuticals PLC, Otonomy Inc and few others.

Research Methodology: Global Hyperacusis Drug Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global hyperacusis drug market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 5400.00
  • 4200.00